TruAlt Bioenergy

{
  "main_header": {
    "sid": 10039792,
    "name": "TruAlt Bioenergy",
    "stock_name": "TruAlt Bioenergy",
    "full_name": "TruAlt Bioenergy Ltd",
    "name_url": "stocks-analysis/trualt-bioenergy",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "429.65",
    "chg": -2.15,
    "chgp": "-0.5%",
    "dir": -1,
    "prev_price": "431.80",
    "mcapval": "3,684.36 Cr",
    "mcap": "Small Cap",
    "scripcode": 544545,
    "symbol": "TRUALT",
    "ind_name": "Commodity Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE0MWH01014",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "35.82 k",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/trualt-bioenergy-10039792-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "TruAlt Bioenergy Gains 13.35%: 4 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-gains-1335-4-key-factors-driving-the-weeks-volatility-3825503",
        "imagepath": "",
        "date": "2026-02-07 09:00:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens week at Rs.380.05 amid broad market weakness</p>\n                    <p><strong>3 Feb:</strong> Strong rebound with 6.33% gain to Rs.404.10</p>\n                    <p><strong>4 Feb:</strong> Intraday low hit at Rs.366.35 amid price pressure and margin concerns</p>\n                    <p><strong>5 Feb:</strong> Recovery with 6.63% gain to Rs.407.95 following stabilised quarterly results</p>\n                    <p><strong>6 Feb:</strong> Intraday high of Rs.445 and 7.4% surge closes week at Rs.431.80</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-labe..."
      },
      {
        "title": "TruAlt Bioenergy Ltd Hits Intraday High with 7.4% Surge on 6 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-ltd-hits-intraday-high-with-74-surge-on-6-feb-2026-3824573",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TruAltBioenergy_priceRelatedfactors_3824573.png",
        "date": "2026-02-06 15:48:18",
        "description": "TruAlt Bioenergy Ltd recorded a robust intraday performance on 6 Feb 2026, surging 7.4% to touch a day’s high of Rs 445, significantly outperforming the Commodity Chemicals sector and broader market indices."
      },
      {
        "title": "Are TruAlt Bioenergy Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-trualt-bioenergy-ltd-latest-results-good-or-bad-3821089",
        "imagepath": "",
        "date": "2026-02-04 19:24:35",
        "description": "TruAlt Bioenergy Ltd's latest financial results for Q3 FY26 present a complex picture of operational performance. The company achieved a notable revenue growth of 520.96% quarter-on-quarter, reaching ₹713.24 crores, which reflects a strong recovery in demand within the commodity chemicals sector. Year-on-year, revenue also grew by 71.82%, indicating a positive trend in sales performance compared to the previous year.\n\nHowever, this significant top-line growth did not translate into proportional profitability. The net profit for the quarter was reported at ₹69.33 crores, which, while representing a substantial quarter-on-quarter increase of 282.74%, showed a decline of 7.79% compared to the same quarter last year. This suggests that despite higher sales, the company's ability to convert revenue into profit has weakened.\n\nThe operating margin for TruAlt Bioenergy has come under pressure, decreasing to 18.79% ..."
      },
      {
        "title": "TruAlt Bioenergy Reports Stabilised Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-reports-stabilised-quarterly-performance-amid-margin-pressures-3820583",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TruAltBioenergy_fintrenddot_3820583.png",
        "date": "2026-02-04 11:00:20",
        "description": "TruAlt Bioenergy Ltd has reported a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of negative trends. While revenue and profitability metrics have shown notable growth compared to the previous four-quarter averages, recent margin pressures and subdued six-month PAT growth highlight ongoing challenges for the commodity chemicals player."
      },
      {
        "title": "TruAlt Bioenergy Q3 FY26: Strong Revenue Recovery Masks Margin Compression Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/trualt-bioenergy-q3-fy26-strong-revenue-recovery-masks-margin-compression-concerns-3820543",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TruAltBioenergy_quaterlyResult_3820543.png",
        "date": "2026-02-04 09:56:22",
        "description": "TruAlt Bioenergy Ltd., a small-cap commodity chemicals manufacturer, reported consolidated net profit of ₹69.33 crores for Q3 FY26, marking a dramatic reversal from the ₹37.94 crore loss posted in Q2 FY26. However, the profit declined 7.79% year-on-year from ₹75.19 crores in Q3 FY25, raising questions about the sustainability of the company's recovery amid persistent margin pressures. The stock declined 4.32% to ₹386.65 following the results announcement, reflecting investor concerns about operational efficiency despite the sequential improvement."
      },
      {
        "title": "TruAlt Bioenergy Ltd Hits Intraday Low Amid Price Pressure on 4 Feb 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-ltd-hits-intraday-low-amid-price-pressure-on-4-feb-2026-3820088",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TruAltBioenergy_priceRelatedfactors_3820088.png",
        "date": "2026-02-04 09:35:02",
        "description": "TruAlt Bioenergy Ltd experienced a significant intraday decline on 4 Feb 2026, touching a low of Rs 366.35, down 9.34% from the previous close. The stock underperformed its sector and the broader market, reflecting immediate selling pressure and heightened volatility despite a recovering Sensex."
      },
      {
        "title": "TruAlt Bioenergy Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trualt-bioenergy-ltd-is-rated-strong-sell-3814153",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TruAltBioenergy_mojoScore_3814153.png",
        "date": "2026-02-01 10:10:22",
        "description": "TruAlt Bioenergy Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "TruAlt Bioenergy Surges 19.03% in a Week: Key Drivers Behind the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-surges-1903-in-a-week-key-drivers-behind-the-rally-3812302",
        "imagepath": "",
        "date": "2026-01-31 09:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jan:</strong> Stock hits 52-week and all-time low near Rs.311</p>\n                    <p><strong>28 Jan:</strong> Strong rebound with 6.04% gain on heavy volume</p>\n                    <p><strong>29 Jan:</strong> Continued rally, stock up 6.97%</p>\n                    <p><strong>30 Jan:</strong> Week closes at Rs.380.95, up 0.73%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.320.05</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.380.95</div><div class=\"stat-change positive\">+1..."
      },
      {
        "title": "TruAlt Bioenergy Stock Falls to 52-Week Low of Rs.310.75",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trualt-bioenergy-stock-falls-to-52-week-low-of-rs31075-3805851",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TruAltBioenergy_priceRelatedfactors_3805851.png",
        "date": "2026-01-27 10:57:50",
        "description": "TruAlt Bioenergy’s shares declined to a fresh 52-week low of Rs.310.75 on 27 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on the company’s financial and market performance."
      }
    ],
    "total": 28,
    "sid": "10039792",
    "stock_news_url": "https://www.marketsmojo.com/news/trualt-bioenergy-10039792"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "06-Feb-2026",
      "details": "Please find attached intimation.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "04-Feb-2026",
      "details": "Please find attached the press release on Q3 results of the Company for the quarter and nine months ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "04-Feb-2026",
      "details": "Please find attached the intimation about Schedule of Investors/Analysts Earnings call for the quarter and nine months ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

TruAlt Bioenergy Gains 13.35%: 4 Key Factors Driving the Week’s Volatility

2026-02-07 09:00:08

Key Events This Week

2 Feb: Stock opens week at Rs.380.05 amid broad market weakness

3 Feb: Strong rebound with 6.33% gain to Rs.404.10

4 Feb: Intraday low hit at Rs.366.35 amid price pressure and margin concerns

5 Feb: Recovery with 6.63% gain to Rs.407.95 following stabilised quarterly results

6 Feb: Intraday high of Rs.445 and 7.4% surge closes week at Rs.431.80

Read full news article

TruAlt Bioenergy Ltd Hits Intraday High with 7.4% Surge on 6 Feb 2026

2026-02-06 15:48:18

TruAlt Bioenergy Ltd recorded a robust intraday performance on 6 Feb 2026, surging 7.4% to touch a day’s high of Rs 445, significantly outperforming the Commodity Chemicals sector and broader market indices.

Read full news article

Are TruAlt Bioenergy Ltd latest results good or bad?

2026-02-04 19:24:35

TruAlt Bioenergy Ltd's latest financial results for Q3 FY26 present a complex picture of operational performance. The company achieved a notable revenue growth of 520.96% quarter-on-quarter, reaching ₹713.24 crores, which reflects a strong recovery in demand within the commodity chemicals sector. Year-on-year, revenue also grew by 71.82%, indicating a positive trend in sales performance compared to the previous year. However, this significant top-line growth did not translate into proportional profitability. The net profit for the quarter was reported at ₹69.33 crores, which, while representing a substantial quarter-on-quarter increase of 282.74%, showed a decline of 7.79% compared to the same quarter last year. This suggests that despite higher sales, the company's ability to convert revenue into profit has weakened. The operating margin for TruAlt Bioenergy has come under pressure, decreasing to 18.79% ...

Read full news article

TruAlt Bioenergy Reports Stabilised Quarterly Performance Amid Margin Pressures

2026-02-04 11:00:20

TruAlt Bioenergy Ltd has reported a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of negative trends. While revenue and profitability metrics have shown notable growth compared to the previous four-quarter averages, recent margin pressures and subdued six-month PAT growth highlight ongoing challenges for the commodity chemicals player.

Read full news article

TruAlt Bioenergy Q3 FY26: Strong Revenue Recovery Masks Margin Compression Concerns

2026-02-04 09:56:22

TruAlt Bioenergy Ltd., a small-cap commodity chemicals manufacturer, reported consolidated net profit of ₹69.33 crores for Q3 FY26, marking a dramatic reversal from the ₹37.94 crore loss posted in Q2 FY26. However, the profit declined 7.79% year-on-year from ₹75.19 crores in Q3 FY25, raising questions about the sustainability of the company's recovery amid persistent margin pressures. The stock declined 4.32% to ₹386.65 following the results announcement, reflecting investor concerns about operational efficiency despite the sequential improvement.

Read full news article

TruAlt Bioenergy Ltd Hits Intraday Low Amid Price Pressure on 4 Feb 2026

2026-02-04 09:35:02

TruAlt Bioenergy Ltd experienced a significant intraday decline on 4 Feb 2026, touching a low of Rs 366.35, down 9.34% from the previous close. The stock underperformed its sector and the broader market, reflecting immediate selling pressure and heightened volatility despite a recovering Sensex.

Read full news article

TruAlt Bioenergy Ltd is Rated Strong Sell

2026-02-01 10:10:22

TruAlt Bioenergy Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.

Read full news article

TruAlt Bioenergy Surges 19.03% in a Week: Key Drivers Behind the Rally

2026-01-31 09:00:07

Key Events This Week

27 Jan: Stock hits 52-week and all-time low near Rs.311

28 Jan: Strong rebound with 6.04% gain on heavy volume

29 Jan: Continued rally, stock up 6.97%

30 Jan: Week closes at Rs.380.95, up 0.73%

Week Open

Rs.320.05

Week Close

Rs.380.95

+1...

Read full news article

TruAlt Bioenergy Stock Falls to 52-Week Low of Rs.310.75

2026-01-27 10:57:50

TruAlt Bioenergy’s shares declined to a fresh 52-week low of Rs.310.75 on 27 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on the company’s financial and market performance.

Read full news article

View All News